Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abducens nerve paralysis
acute disseminated encephalomyelitis
acute disseminated encephalomyelitis, multiphasic
adenylate kinase 5 autoantibodies
advances in neurology
afebrile
affect, flat
aggression
agitation
alternative medicine
alveolar hypoventilation
Alzheimer's disease
Alzheimer's disease, diagnosis of
Alzheimer's disease, preclinical
amnesia
amnesia, anterograde
amygdala
amygdalohippocampectomy
amyloid beta protein
amyloid imaging
amyloid plaques
ANA
angiography, cerebral
anti Hu antibody
anti Ro antibody
anticonvulsants
anticonvulsants, effectiveness
anticonvulsants, selection of
anticonvulsants, untoward effects of
antiviral agents
anxiety
aphasia
apolipoprotein E
arrhythmia, cardiac
arteriovenous malformation
arteriovenous malformation, cerebral
astrocytoma
asymptomatic
ataxia
ataxia, cerebellar
atypical
aura
autism
autoantibodies
autoimmune cerebellar ataxia
autoimmune disease
autoimmune GFAP astrocytopathy
automatisms
autonomic dysfunction
B cell lymphoma
Babinski sign
barbiturate anesthesia
basal ganglia
basal ganglia, lesion of
behavior
behavior, combative
behavioral disorder
biologic markers
blindness
blindness, sudden
brain atrophy
brain biopsy
brain volume
brainstem, lesion of
burst suppression pattern, electroencephalogram
carcinoma
carcinoma of lung
CAT scan
CAT scan, abnormal
CAT scan, emission
CAT scan, emission, abnormal
CAT scan, false negative
CAT scan, metrizamide
cavernous hemangioma
CD19-directed chimeric antigen receptor T-cell therapy
central nervous system, infection of
cerebellar lesion
cerebellar pontine angle
cerebellar pontine angle tumor
cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy
cerebral cortex
cerebral cortical atrophy
cerebral edema
cerebral edema, vasogenic
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, biochemical markers of CNS disease
cerebrospinal fluid, elevated protein of
cerebrospinal fluid, oligoclonal IgG in
chemotherapy, CNS treatment and complications with
children
Clinical Pathologic Conference(C.P.C.)
cognition
coma
coma, medically induced
complications
confusion
confusional state, acute
corpus callosotomy
corpus callosum
corpus callosum, lesion of
cortical dysplasia, focal
cortical resection
cost effectiveness
cytokine release syndrome
cytomegalovirus infection
deep gray nuclei
degenerative diseases of CNS
delusion
dementia
dementia, diagnostic evaluation of
dementia, early detection
dementia, frontotemporal
dementia, rapidly progressive
dementia, screening for
demyelinating disease
diagnostic criteria
diarrhea
diet
differential diagnosis
diplopia
disability, neurological
disorientation
drowsiness
dysarthria
dyskinesia
dyskinesia, buccal lingual facial
efficacy
electroencephalogram
electroencephalogram, abnormalities of
electroencephalogram, periodic complexes
electroencephalogram, video monitoring with
encephalitis
encephalitis, autoimmune
encephalitis, focal
encephalitis, unknown etiology
encephalitis, viral
encephalomalacia
encephalomyelitis
encephalopathy
encephalopathy, acute
encephalopathy, limbic
encephalopathy, post traumatic
epilepsy
epilepsy monitoring unit
epileptic encephalopathy
episodic disorders
episodic neurologic deficits
eye movement, disorders of
face, numbness of
facial asymmetry
facial weakness
familial
febrile infection-related epilepsy syndrome
fever
flu-like illness
gammaglobulin therapy, intravenous
gender
Geschwind, Norman
GFAP-IgG
glioma
gliomatosis cerebri
gliosis
glutamic acid decarboxylase, antibody
glyphosate
gray matter
hallucination
hallucination, auditory
hamartoma
head injury
head injury, prognosis in
headache
headache, recurrent
hemimyoclonic jerks
hemiparesis
hemispherectomy
heralding manifestation
herbicide
herpes simplex encephalitis
hiccoughs
hippocampal atrophy
hippocampus
hippocampus, hyperintense
histopathology
human herpesvirus 6
hyperactivity
hypersomnia
hyponatremia
hypothalamus, lesion of
hypothyroidism
immune effector cell-associated neurotoxicity syndrome
immune-related adverse events
immunohistochemistry
immunologic disease
immunosuppression
immunosuppressive agents
immunotherapy
inattention
incidentaloma
inclusion bodies
inclusion bodies, intracytopasmic
infection
insular cortex
insular cortex, lesion
insular cortex, lesion, bilateral
intellectual deficit
intellectual deterioration
ketogenic diet
learning disability
learning disability, in children
lethargy
leucine rich glioma inactivated 1 antibodies
leukopenia
level of consciousness
level of consciousness, decreased
limbic encephalitis
limbic system
limbic-predominant age-related TDP-43 encephalopathy
lobar atrophy
lymphadenopathy, hilar
lymphoma
lymphoma, systemic
malformation, vascular
malformation, vascular, cerebral
malignancy screen
memory, defect of recent
memory, evaluation of
memory, impairment of
meningeal enhancement
meningioma
meningitis
meningitis, neurologic aspects and complications of
meningitis, seizures with
meningoencephalomyelitis
mental retardation
mesial temporal lobe
mesial temporal lobe epilepsy
mesial temporal sclerosis
mesial temporal sclerosis, bilateral
microhemorrhage, intracerebral
microinfarcts
midbrain, lesion of
middle cerebellar peduncle, lesion
mild cognitive impairment
mimics
misdiagnosis
mitochondrial disease
mortality
movement disorder
MRI
MRI pattern
MRI, abnormal
MRI, abnormal, seizure causing
MRI, CAT scan compared to
MRI, contrast enhanced
MRI, disappearing lesion on
MRI, false negative
MRI, field strength, high
MRI, FLAIR
MRI, functional
MRI, gyral enhancement
MRI, head injury
MRI, incidental finding
MRI, indications for
MRI, morphometyry
MRI, negative
MRI, ring sign
MRI, ring sign, open
MRI, serial
MRI, spinal cord
MRI, volumetry
MRI, voxel-based morphometry
MRS
multiple sclerosis
multiple sclerosis, misdiagnosis
multiple subpial transection
myelitis, longitudinal
myoclonic jerks
myoclonus
negative
neoplasm, primary intracerebral
neoplasm, primary intracranial
neoplasm, primary of CNS
neoplasm, primary of CNS-children
neurologic disease, diagnoses of
neuromyelitis optica (Devic's disease)
neuromyelitis optica spectrum disorder
neuronal migration disorder
neuropathology
neuropathology, brain
neuropathy
neurosyphilis
neurotoxin
NMDA antagonists
NMDA receptors
normal
nystagmus
nystagmus, primary position of gaze
ocular dipping
old age, neurology of
optic chiasm
optic chiasm, lesion of
pain
pain, leg
pallor
paranoia
Parkinsonism syndrome
periaqueductal lesion
perseveration
personality change
personality disorder
plasmapheresis
PLEDs
PLEDs, bilateral independent
PLEDs, etiology of
pleocytosis of cerebrospinal fluid
posterior fossa, lesion of
postictal neurologic deficits
postictal psychosis
potassium channel antibodies
precipitating factors
preclinical
prevention of neurologic disorders
prognosis
progressive neurologic disorder
prosopagnosia
psychiatric problems in neurologic disorders
psychological testing
psychosis
psychosurgery
psychotic behavior
pulmonary nodules
quadrantanopsia, superior
quadriparesis
rapidly progressing neurologic illness
recurrent
release phenomena
religiosity
remote effect of cancer on the nervous system
reversible neurologic disorder
review article
rheumatoid arthritis factor(R.A.factor)
risk factors
salivation, excessive
schizophrenia
screening
sedimentation rate, elevated
seizure
seizure, adult onset
seizure, children
seizure, classification of
seizure, complications following
seizure, diagnosis of
seizure, drug resistance
seizure, elderly
seizure, equivalents
seizure, etiology of
seizure, febrile
seizure, febrile, risk of epilepsy following
seizure, focal
seizure, focus
seizure, intractable
seizure, intractable, treatment of
seizure, medication failure
seizure, new onset
seizure, prevention of
seizure, prognosis in adults
seizure, prognosis in childhood
seizure, psychomotor-frontal lobe
seizure, psychomotor-temporal lobe
seizure, psychomotor-temporal lobe, interictal behavior
seizure, psychomotor-temporal lobe, prognosis of
seizure, psychosocial aspects of
seizure, recurrent
seizure, risk factors for
seizure, surgical treatment of
seizure, treatment of
seizure, treatment of, polytherapy
seizure, treatment, adjunctive therapy
seizure, workup of
serologic testing
serologic testing of cerebrospinal fluid
seronegative
sexual behavior, disorder of
single photon emission computed tomography
Sjogren's syndrome
Sjogren's syndrome, neurologic manifestations of
sleep
small vessel disease
speech disorder
speech, slowed
standing difficulty
stare
status epilepticus
status epilepticus, intractable
steroid therapy, CNS treatment and complications with
stimulation, deep brain
subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease
subacute sclerosing panencephalitis, adult onset
subinsular cortex
symmetric brain lesions
syphilis, diagnosis and treatment
syphilis, neurologic complications with
tau protein
TDP-43 proteinopathy
temporal horn, enlarged
temporal lobe
temporal lobe, atrophy
temporal lobe, lesion
temporal lobe, lesion, bilateral
temporal lobe, status
temporal lobe, tumor
temporal lobectomy
temporal lobectomy, complications
teratoma
teratoma, ovarian
thalamus, lesion of
thyroid function tests
thyroiditis
tonic spasms
toxic encephalopathy
transient neurologic deficit
treatment of neurologic disorder
tremor
tuberous sclerosis
vaccination, neurologic complications with
vagus nerve stimulation
vasculopathy
ventricular enlargement
violent behavior
viral infection, CNS
visual field defect
visual loss
visual loss, sudden
water channel antibodies
weight loss
whistling
white matter disease
word-finding difficulty
workup
Showing articles 1150 to 1200 of 2511 << Previous Next >>

Olfactory Dysfunction in Multiple Sclerosis:Relation to Longitudinal Changes in Plaque Numbers in Central Olfactory Structures
Neurol 53:880-882, Doty,R.L.,et al, 1999

Isolated Trochlear Nerve Palsy in Patients with Multiple Sclerosis
Neurol 53:877-879, Jacobson,D.M.,et al, 1999

Rehabilitation of Persons With Traumatic Brain Injury
JAMA 282:974-983,989, NIH Consensus Development Panel on Rehab with TBI, 1999

Multiple Sclerosis That is Progressive From the Time of Onset, Clinical Characteristics and Progression of Disability
Arch Neurol 56:1138-1142, Andersson,P.B.,et al, 1999

The Clinical Course of Neuromyelitis Optica (Devic's Syndrome)
Neurol 53:1107-1114, Wingerchuk,D.M.,et al, 1999

Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis and Future Directions for Multiple Sclerosis Therapeutics
Arch Neurol 56:1079-1084, Rudick,R.A., 1999

Safety and Factors Related to Survival After Percutaneous Endoscopic Gastrostomy in ALS
Neurol 53:1123-1125, Chio,A.,et al, 1999

Brachial Amyotrophic Diplegia, A Slowly Progressive Motor Neuron Disorder
Neurol 53:1071-1076, Katz,J.S.,et al, 1999

New Developments in the Neurobiology of the Tuberous Sclerosis Complex
Neurol 53:1384-1390, Crino,P.B.&Henske,E.P., 1999

Treatment Recommendations for Interferon-B in Multiple Sclerosis
JNNP 67:561-566, Polman,C.H.,et al, 1999

General Neurologist and Subspecialist Care for Multiple Sclerosis, Patients' Perceptions
Neurol 53:1190-1197, Vickrey,B.G.,et al, 1999

Multiple Sclerosis, Side Effects of Interferon Beta Therapy and Their Management
Neurol 53:1622-1627, Walther,E.U.&Hohlfeld,R., 1999

An Algorithm for ALS Diagnosis and Management
Neurol 53:S58-S62, Swash,M., 1999

Isolated Cranial Nerve Palsies Due to Brainstem Lesions
Muscle & Nerve 22:1168-1176, Thomke,F., 1999

Interferon-B-1a in Relapsing-Remitting Multiple Sclerosis:Effect on Hypointense Lesion Volume on T1 Weighted Images
JNNP 67:579-584, Gasperini,C.,et al, 1999

Leukoencephalopathy and Raised Brain Lactate from Heroin Vapor Inhalation ("Chasing the Dragon")
Neurol 53:589-1048, Kriegstein,A.R., et al, 1999

Magnetic Resonance Imaging Features of Solitary Inflammatory Brain Masses
J Neuroimag 8:8-14, Bakshi,R.,et al, 1998

Flail Arm Syndrome: A Distinctive Variant of Amyotrophic Lateral Sclerosis
JNNP 65:950-951, Hu, M.T.M.,et al, 1998

Diffusion Magnetic Resonance Imaging in Multiple Sclerosis
JNNP 64:S80-S84, Horsfield,M.A.,et al, 1998

Current Immunotherapy in Multiple Sclerosis
Immunology and Cell Biology 76:55-64, Bashir,K.&Whitaker,J.N., 1998

Subdural Haemorrhages in Infants:Population Based Study
BMJ 317:1558-1561,1538, Jayawant,S.,et al, 1998

Early Structural Changes in Acute MS Lesions Assessed by Serial magnetization Transfer Studies
Neurol 51:1150-1155, Dousset,V.,et al, 1998

Devic's Neuromyelitis Optica:A Prospective Study of Seven Patients Treated with Prednisone and Azathioprine
Neurol 51:1219-1220, Mandler,R.N.,et al, 1998

Interferon B Therapy for Multiple Sclerosis
Lancet 352:1486-1487, Goodkin,D.E., 1998

Interferons in the Treatment of Multiple Sclerosis,Do They Prevent the Progression of the Disease?
Arch Neurol 55:1578-1580,1583, Rice,G.&Ebers,G, 1998

Interferons Should be Used to Treat Most Patients with MS
Arch Neurol 55:1581-1583, Herndon,R.M.&Jacobs,L, 1998

Randomised Double-Blind Placebo-Controlled Study of Interferon B-1a in Relapsing/Remitting Multiple Sclerosis
Lancet 352:1498-1504,1486, PRISMS, 1998

Placebo-Controlled Multicentre Randomised Trial of Interferon B-1b in Treatment of Secondary Progressive Multiple Sclerosis
Lancet 352:1491-1497,1486, European Study Group on Interferon B-1b in Seconda, 1998

Neuropsychiatric Sequelae One Year after a Minor Head Injury
JNNP 65:899-902,809, Deb,S.,et al, 1998

Clinical Approach to Inherited Peroxisomal Disorders: A Series of 27 Patients
Ann Neurol 44:720-730,713, Baumgartner,M.R.,et al, 1998

Amelioration of Flulike Symptoms at the Onset of Interferon B-1b Therapy in Multiple Sclerosis by Low-Dose Oral Steriods is Related to a Decrease in Interleukin-6 Induction
Ann Neurol 44:682-685, Martinez-Caceres,E.M.,et al, 1998

Neutralizing Antibodies to Interferon B-1a and Interferon B-1b in MS Patients are Cross-Reactive
Neurol 51:1698-1702, Khan,O.A. & Dhib-Jalbut,S., 1998

Tolterodine for Overactive Bladder
The Medical Letter 40:101-102, , 1998

Clinicopath Conf,Sarcoidosis,with Involvement of Spinal Cord,Brain,Mediastinal Lymph Nodes and ? Lung,Case 35-1998
NEJM 339:1534-1541, , 1998

Clinicopath Conf,Syndrome of Mitochondrial Encephalopathy,Lactic Acidosis,and Stroke-Like Episodes (MELAS),Case 39-1998
NEJM 339:1914-1923, , 1998

Attitudes of Patients with Amyotrophic Lateral Sclerosis and Their Care Givers Toward Assisted Suicide
NEJM 339:967-973,987, Ganzini,L.,et al, 1998

Olfactory Dysfunction in Guamanian ALS,Parkinsonism,and Dementia
Neurol 51:1672-1677, Ahlskog,J.E.,et al, 1998

The Predictive Value of CSF Ologoclonal Banding for MS 5 Years After Optic Neuritis
Neurol 51:885-887, Cole,S.R.,et al, 1998

The Phenotypic Spectrum of CADASIL:Clinical Findings in 102 Cases,
Ann Neurol 44:731-739,715, Dichgans,M.,et al, 1998

Surgical Treatment of Epilepsy in Tuberous Sclerosis,Strategies and Results in 18 Patients
Neurol 51:1263-1269, Guerreiro,M.M.,et al, 1998

Atypical Herpes Simplex Virus Encephalitis Diagnosed by PCR Amplification of Viral DNA from CSF
Neurol 51:554-559, Fodork,P.A.,et al, 1998

An Analysis of Extended Survival in Patients with Amyotrophic Lateral Sclerosis Treated with Riluzole
Arch Neurol 55:526-528, Riviere,M.,et al, 1998

Magnetic Resonance Imaging of Muscle in Amyotrophic Lateral Sclerosis
Neurol 51:110-113, Bryan,W.W.,et al, 1998

Imaging the Brain, Part 1 & 2
NEJM 338:812-820, 889-8961998., Gilman,S., 1998

Near-Fatal Heat Stroke During the 1995 Heat Wave in Chicago
Ann Int Med 129:173-181, Damatte,J.E.,et al, 1998

Incidence and Significance of Neutralizing Antibodies to Interferon Beta-1a in Multiple Sclerosis
Neurol 50:1266-1272, 12061998., Rudick,R.A.,et al, 1998

Acute Leukoencephalopathies:Differential Diagnosis and Investigation
The Neurologist 4:148-166, Weinshenker,B.G.,et al, 1998

Migraine and Reduced Work Performance, A Population-Based Diary Study
Neurol 50:1741-1745, Von Korff,M.,et al, 1998

Clinicopath Conf
Subacute Sclerosing Panencephalitis, Case 15-1998, NEJM 338:1448-1456998., , 1998

Limbic Encephalitis:Comparison of FDG PET and MR Imaging Findings
AJR 170:1659-1660, Provenzale,J.M.,et al, 1998



Showing articles 1150 to 1200 of 2511 << Previous Next >>